Taylor, Cottrill, Erickson & Associates, Inc. Moleculin Biotech In Transaction History

Taylor, Cottrill, Erickson & Associates, Inc.

  • $359 Million
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 15, 2021
SELL
N/A
-16,964 Closed
0 $0
Q1 2021

Apr 14, 2021
SELL
N/A
-84,817 Reduced 83.33%
16,964 $69,000
Q4 2019

Jan 14, 2020
SELL
N/A
-50,000 Reduced 32.94%
101,781 $93,000
Q1 2019

Apr 29, 2019
BUY
N/A
30,000 Added 24.63%
151,781 $123,000
Q4 2018

Jan 29, 2019
BUY
N/A
24,781 Added 25.55%
121,781 $127,000
Q1 2018

Apr 23, 2018
BUY
N/A
97,000 New
97,000 $175,000
Track This Portfolio

Track Taylor, Cottrill, Erickson & Associates, Inc. Portfolio

Follow Taylor, Cottrill, Erickson & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor, Cottrill, Erickson & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Taylor, Cottrill, Erickson & Associates, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email